Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.

1998 • 2,422 citations

Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.

1998 • 2,270 citations

Muscarinic Receptor Subtypes

1990 • 1,346 citations

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

1996 • 1,047 citations

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

1999 • 750 citations

Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice

1997 • 365 citations

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1995 • 318 citations

5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia

1996 • 287 citations

Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease

1995 • 221 citations

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation

2000 • 219 citations

Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment

2001 • 219 citations

Delta Sleep Deficits in Schizophrenia

1998 • 189 citations

Therapeutic opportunities from muscarinic receptor research

2001 • 173 citations

Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice

2000 • 147 citations

The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.

1996 • 145 citations

Identification and Mapping of Keratinocyte Muscarinic Acetylcholine Receptor Subtypes in Human Epidermis11Presented at the 17th International Congress of Biochemistry and Molecular Biology in conjunction with the Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Francisco, California, August 25 1997, and at the Third Tricontinental Meeting of the Society for Investigative Dermatology, the European Society for Dermatological Research and the Japanese Society for …

1998 • 122 citations

Elucidating the role of muscarinic receptors in psychosis

2001 • 121 citations

Cholinergic aspects of schizophrenia

1999 • 118 citations

Treatment of schizophrenia

1995 • 106 citations

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

2001 • 98 citations

Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors

1999 • 62 citations

Olanzapine: a novel atypical neuroleptic agent

1997 • 60 citations

Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics

1983 • 55 citations

Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia

2000 • 53 citations

Role of the M1 receptor in regulating circadian rhythms

2001 • 32 citations

Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia A PREDICTED CORTICAL SEROTONERGIC/CHOLINERGIC/GABAERGIC INTERFACE AS A SITE OF PATHOLOGY IN SCHIZOPHRENIA

2001 • 27 citations

Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex

1990 • 21 citations